Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq

PURPOSE: The management of triple-negative breast cancer (TNBC) remains a significant clinical challenge due to the lack of effective targeted therapies. Inhibitors of the cyclin-dependent kinases 4 and 6 (CDK4/6) are emerging as promising therapeutic agents against TNBC; however, cells can rapidly...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanceta, Lilibeth, Lypova, Nadiia, O’Neill, Conor, Li, Xiaohong, Rouchka, Eric, Chesney, Jason, Imbert-Fernandez, Yoannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019424/
https://www.ncbi.nlm.nih.gov/pubmed/33599863
http://dx.doi.org/10.1007/s10549-021-06127-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019424/
https://www.ncbi.nlm.nih.gov/pubmed/33599863
http://dx.doi.org/10.1007/s10549-021-06127-5

Ejemplares similares